More Care Guides Browse by topicAll guidesBenefits & Allowances (17)Equipment & Devices (16)Home Care & CDPAP (11)Appeals & Denials (5)Bills & Costs (6)Medications (7)Plans & Coverage (6)Living With a Condition (6)Working With an Advocate (49)Medications · Aug 7, 2026What Is the Medicare GLP-1 Bridge Program and Who Qualifies?The Medicare GLP-1 Bridge covers Wegovy, Zepbound KwikPen and Foundayo at $50/month. Learn who qualifies by BMI tier, which drugs are covered, and how to apply.Medications · Jul 24, 2026How to Get GLP-1 and Neuropathy Medication Covered on the Same Medicare PlanFind out how to get both GLP-1 weight-loss drugs and neuropathy medications covered on the same Medicare plan - two separate tracks, one coordinated approach.Medications · Jul 18, 2026EPIC in New York: Who Qualifies and How Much It Cuts Your Prescription CostsNew York's EPIC program lowers drug costs for residents 65+ on Medicare Part D. Income limits for the Fee and Deductible plans, copay tiers, and how to enroll.Medications · Jul 1, 2026Why the GLP-1 Drug You Were Approved For Suddenly Costs $1,200 Instead of the Promised $50Approved for a GLP-1 like Wegovy or Zepbound but quoted $1,200? Learn why insurance approval doesn't guarantee a low copay and what steps to take next.Medications · Jun 30, 2026GLP-1 Bridge Program vs Compounded Semaglutide: Real CostsIs compounded semaglutide cheaper than Medicare's $50 GLP-1 Bridge? Real cost comparison, eligibility fine print, and what to plan for after December 2027.Medications · Jun 5, 2026GLP-1 Side Effects on Medicare: When to Call Your Advocate vs Your DoctorStarting a GLP-1 on Medicare in 2026? Learn which side effects require your doctor, which need a patient advocate, and how to appeal a GLP-1 denial before your 60-day deadline.Medications · Jun 3, 2026How a Patient Advocate Helps Medicare Patients Get GLP-1 Drugs Covered (Ozempic, Wegovy, Mounjaro)Medicare covers Wegovy and Zepbound for $50/month under the new GLP-1 Bridge Program, but approval is complex. Get expert help navigating prior authorization.